{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:33:01Z","timestamp":1787020381881,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T00:00:00Z","timestamp":1561334400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T00:00:00Z","timestamp":1561334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Natural Science Foundation of Jiangsu Province","award":["BK20181116"],"award-info":[{"award-number":["BK20181116"]}]},{"name":"the Project of Jiangsu Provincial Medical Youth Talent","award":["none"],"award-info":[{"award-number":["none"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12902-019-0390-3","type":"journal-article","created":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T10:37:03Z","timestamp":1561372623000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population"],"prefix":"10.1186","volume":"19","author":[{"given":"Ke-ying","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-huan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-long","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,24]]},"reference":[{"issue":"5","key":"390_CR1","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, Stowasser M, Young WF. The Management of Primary Aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(5):1889\u2013916.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"390_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1210\/er.2017-00054","volume":"38","author":"WF Young","year":"2017","unstructured":"Young WF, Calhoun DA, Lenders JWM, Stowasser M, Textor SC, Young WF, Calhoun DA, Lenders JWM, Stowasser M, Textor SC. Screening for Endocrine hypertension: an Endocrine Society scientific statement. Endocr Rev. 2017;38(2):103\u201322.","journal-title":"Endocr Rev"},{"issue":"8","key":"390_CR3","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005;45(8):1243\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"390_CR4","doi-asserted-by":"publisher","first-page":"5070","DOI":"10.1210\/jc.2005-0681","volume":"18","author":"M Stowasser","year":"2005","unstructured":"Stowasser M, Sharman J, Leano R, Gordon R, Ward G, Cowley D, Marwick T. Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. J Clin Endocrinol Metab. 2005;18(5):5070\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"390_CR5","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","volume":"50","author":"C Catena","year":"2007","unstructured":"Catena C, Colussi GR, Nadalini E, Chiuch A, Gianfagna P, Sechi L. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension. 2007;50(5):911\u20138.","journal-title":"Hypertension."},{"issue":"7","key":"390_CR6","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1097\/HJH.0b013e328360ddf6","volume":"31","author":"X Sang","year":"2013","unstructured":"Sang X, Jiang Y, Wang W, Yan L, Zhao J, Peng Y, Gu W, Chen G, Liu W, Ning G. Prevalence of and risk factors for primary aldosteronism among patients with resistant hypertension in China. J Hypertens. 2013;31(7):1465\u201371.","journal-title":"J Hypertens"},{"issue":"11","key":"390_CR7","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F, Investigators PS. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48(11):2293\u2013300.","journal-title":"J Am Coll Cardiol"},{"issue":"9628","key":"390_CR8","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","volume":"371","author":"S Douma","year":"2008","unstructured":"Douma S, Petidis K, Doumas M, Papaefthimiou P, Triantafyllou A, Kartali N, Papadopoulos N, Vogiatzis K, Zamboulis C. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet. 2008;371(9628):1921\u20136.","journal-title":"Lancet."},{"issue":"11","key":"390_CR9","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1093\/ajh\/hpu053","volume":"27","author":"J Wang","year":"2014","unstructured":"Wang J, Zhang L, Wang F, Liu L, Wang H. Prevalence, awareness, treatment, and control of hypertension in China: results from a National Survey. Am J Hypertens. 2014;27(11):1355\u201361.","journal-title":"Am J Hypertens"},{"issue":"9","key":"390_CR10","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","volume":"58","author":"T Nishikawa","year":"2011","unstructured":"Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, Tamura N, Tanabe A. Task force committee on primary Aldosteronism, the Japan Endocrine Society. Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009. Endocr J. 2011;58(9):711\u201321.","journal-title":"Endocr J"},{"issue":"12","key":"390_CR11","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.jfma.2017.06.004","volume":"116","author":"VC Wu","year":"2017","unstructured":"Wu VC, Hu YH, Er LK, Yen RF, Chang CH, Chang YL, Lu CC, Chang CC, Lin JH, Lin YH, Wang TD, Wang CY, Tu ST, Jeff Chueh SC, Chang CC, Tseng FY, Wu KD. TAIPAI group. Case detection and diagnosis of primary aldosteronism - the consensus of Taiwan Society of Aldosteronism. J Formos Med Assoc. 2017;116(12):993\u20131005.","journal-title":"J Formos Med Assoc"},{"issue":"8","key":"390_CR12","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/ajh.2009.89","volume":"22","author":"VC Wu","year":"2009","unstructured":"Wu VC, Chang HW, Liu KL, Lin YH, Chueh SC, Lin WC, Ho YL, Huang JW, Chiang CK, Yang SY, Chen YM, Wang SM, Huang KH, Hsieh BS, Wu KD. TAIPAI study group. Primary aldosteronism: diagnostic accuracy of the losartan and captopril tests. Am J Hypertens. 2009;22(8):821\u20137.","journal-title":"Am J Hypertens"},{"issue":"12","key":"390_CR13","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/hr.2014.129","volume":"37","author":"C Nakama","year":"2014","unstructured":"Nakama C, Kamide K, Kawai T, Hongyo K, Ito N, Onishi M, Takeya Y, Yamamoto K, Sugimoto K, Rakugi H. The influence of aging on the diagnosis of primary aldosteronism. Hypertens Res. 2014;37(12):1062\u20137.","journal-title":"Hypertens Res"},{"issue":"2","key":"390_CR14","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3803\/EnM.2016.31.2.277","volume":"31","author":"JH Kim","year":"2016","unstructured":"Kim JH, Park KS, Hong AR, Shin CS, Kim SY, Kim SW. Diagnostic role of captopril challenge test in Korean subjects with high aldosterone-to-renin ratios. Endocrinol Metab (Seoul). 2016;31(2):277\u201383.","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"2","key":"390_CR15","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.107.091827","volume":"50","author":"GP Rossi","year":"2007","unstructured":"Rossi GP, Belfiore A, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Palumbo G, Rizzoni D, Rossi E, Agabiti-Rosei E, Pessina AC, Mantero F. Primary Aldosteronism prevalence in Italy study I. comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension. 2007;50(2):424\u201331.","journal-title":"Hypertension."},{"issue":"6","key":"390_CR16","doi-asserted-by":"publisher","first-page":"e2602","DOI":"10.1097\/MD.0000000000002602","volume":"95","author":"W Feng","year":"2016","unstructured":"Feng W, Cai Q, Yuan W, Liu Y, Bardeesi AS, Wang J, Chen J, Huang H. Low response of renin\u2013angiotensin system to sodium intake intervention in Chinese hypertensive patients. Medicine. 2016;95(6):e2602.","journal-title":"Medicine."},{"issue":"1","key":"390_CR17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1210\/jc.2015-2840","volume":"101","author":"Y Li","year":"2016","unstructured":"Li Y, Liu Y, Li J, Wang X, Yu Y. Sodium infusion test for diagnosis of primary Aldosteronism in Chinese population. J Clin Endocrinol Metab. 2016;101(1):89\u201395.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"390_CR18","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1210\/jc.2008-0104","volume":"93","author":"JW Funder","year":"2008","unstructured":"Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF Jr, Montori VM, Endocrine S. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(9):3266\u201381.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"390_CR19","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1161\/01.HYP.0000014324.68506.CA","volume":"39","author":"OL Castro","year":"2002","unstructured":"Castro OL, Yu X, Kem DC. Diagnostic value of the post-captopril test in primary aldosteronism. Hypertension. 2002;39(4):935\u20138.","journal-title":"Hypertension."},{"issue":"5","key":"390_CR20","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1365-2265.1992.tb02252.x","volume":"36","author":"C Hambling","year":"1992","unstructured":"Hambling C, Jung RT, Gunn A, Browning MC, Bartlett WA. Re-evaluation of the captopril test for the diagnosis of primary hyperaldosteronism. Clin Endocrinol. 1992;36(5):499\u2013503.","journal-title":"Clin Endocrinol"},{"issue":"3","key":"390_CR21","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1177\/1470320310390405","volume":"12","author":"C Westerdahl","year":"2011","unstructured":"Westerdahl C, Bergenfelz A, Isaksson A, Valdemarsson S. Captopril suppression: limitations for confirmation of primary aldosteronism. J Renin-Angiotensin-Aldosterone Syst. 2011;12(3):326\u201332.","journal-title":"J Renin-Angiotensin-Aldosterone Syst"},{"issue":"1","key":"390_CR22","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1161\/HYPERTENSIONAHA.117.10197","volume":"71","author":"Y Song","year":"2018","unstructured":"Song Y, Yang S, He W, Hu J, Cheng Q, Wang Y, Luo T, Ma L, Zhen Q, Zhang S, Mei M, Wang Z, Qing H, Bruemmer D, Peng B, Li Q. Chongqing primary Aldosteronism study G. confirmatory tests for the diagnosis of primary Aldosteronism: a prospective diagnostic accuracy study. Hypertension. 2018;71(1):118\u201324.","journal-title":"Hypertension."},{"issue":"3","key":"390_CR23","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1210\/jc.2017-01530","volume":"103","author":"X Meng","year":"2018","unstructured":"Meng X, Li Y, Wang X, Li J, Liu Y, Yu Y. Evaluation of the saline infusion test and the captopril challenge test in Chinese patients with primary Aldosteronism. J Clin Endocrinol Metab. 2018;103(3):853\u201360.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"390_CR24","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/hr.2013.69","volume":"36","author":"T Shimosawa","year":"2013","unstructured":"Shimosawa T. Salt, the renin angiotensin aldosterone system and resistant hypertension. Hypertension Res. 2013;36(8):657\u201360.","journal-title":"Hypertension Res"},{"issue":"3","key":"390_CR25","doi-asserted-by":"publisher","first-page":"182","DOI":"10.5414\/CNP74182","volume":"74","author":"M Koch","year":"2010","unstructured":"Koch M, Aker S, Haastert B, Rump LC. Clinical relevance of dietary salt intake on aldosterone and the aldosterone-to-renin ratio as screening parameters for primary aldosteronism. Clin Nephrol. 2010;74(3):182\u20139.","journal-title":"Clin Nephrol"},{"issue":"11","key":"390_CR26","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1210\/jc.2016-1963","volume":"101","author":"R Baudrand","year":"2016","unstructured":"Baudrand R, Guarda FJ, Torrey J, Williams G, Vaidya A. Dietary sodium restriction increases the risk of misinterpreting mild cases of primary Aldosteronism. J Clin Endocrinol Metab. 2016;101(11):3989\u201396.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"390_CR27","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1097\/HJH.0000000000000341","volume":"32","author":"N Okuda","year":"2014","unstructured":"Okuda N, Stamler J, Brown IJ, Ueshima H, Miura K, Okayama A, Saitoh S, Nakagawa H, Sakata K, Yoshita K, Zhao L, Elliott P, Group IR. Individual efforts to reduce salt intake in China, Japan, UK, USA: what did people achieve? The INTERMAP population study. J Hypertens. 2014;32(12):2385\u201392.","journal-title":"J Hypertens"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-019-0390-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12902-019-0390-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-019-0390-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T19:14:12Z","timestamp":1592853252000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-019-0390-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,24]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["390"],"URL":"https:\/\/doi.org\/10.1186\/s12902-019-0390-3","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,24]]},"assertion":[{"value":"27 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocols complied with the Guidelines of the Ethics Committee of Nanjing Drum Towel Hospital. Informed consent was obtained from all subjects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"65"}}